Asbestos lung cancer lawsuit filings have hit their highest level ever recorded, according to KCIC’s newly released 2025 Asbestos Litigation Year in Review. The report states 1,714 lung cancer lawsuits were filed in 2025. That is a 48 percent increase in lung cancer filings from 10 years ago when 1,156[…]
New Study
Artificial Intelligence Could Help Treat Mesothelioma
Diagnosing lung diseases can be hard because they have many causes and symptoms. Artificial intelligence (AI) may enable faster and more accurate diagnosis. AI could also play a significant role in improving outcomes for mesothelioma patients and other lung diseases. One common lung problem is pleural effusion. This can make[…]
Immunotherapy to Treat Pleural Effusion
Malignant pleural effusion is a serious condition where cancer cells spread to the lining of the lungs. This leads to fluid buildup in the chest cavity. This fluid accumulation can make breathing difficult and is often a sign of advanced lung cancer. Pleural effusion is a common symptom of malignant[…]
Tretinoin, a Derivative of Vitamin A, Could Improve the Anti-Cancer Effects of Chemotherapy on Mesothelioma
Tretinoin, a derivative of vitamin A, is showing potential to enhance the effects of chemotherapy. Combining tretinoin with chemotherapy improved survival rates in mesothelioma in mice. Mesothelioma is a rare type of cancer that is hard to diagnose and treat. It develops from the thin layer of tissue that covers[…]
Researchers are Trying to Figure Out Why Younger People are Getting Mesothelioma
A new study from Memorial Sloan Kettering Cancer Center is raising questions about who develops mesothelioma and why. Researchers identified 273 pleural mesothelioma patients at or under the age of 50 who were treated at the center between 1990 and 2023 and found many had no occupational asbestos exposure history,[…]
Limited Surgery to Limit Symptoms of Pleural Mesothelioma
A new clinical trial at the University of Chicago is testing whether a smaller, symptom-focused surgery can help pleural mesothelioma patients maintain quality of life when tumor removal is not possible. This study looks at surgery differently compared to other trials. Rather than focusing first on complete tumor removal, it[…]
Radiomics to Determine Mesothelioma
Malignant mesothelioma is a challenging cancer to treat. New therapies like T cell receptor fusion constructs (TRuCs) show promise. Determining which patients will benefit from these treatments is important. Radiomics, a field that extracts data from medical images, offers a potential solution. Radiomics may predict treatment responses based on imaging[…]
Collapsed Lung and Mesothelioma
A new article highlights the link between a collapsed lung and mesothelioma. Mesothelioma, caused by asbestos exposure, can present unexpectantly. It often requires many clinical tests for accurate diagnosis and treatment planning. A new study explores the case of a 73-year-old man whose recurrent collapsing lung was found to be[…]
PITAC to Treat Mesothelioma
A Stanford team performed a specialized procedure for pleural mesothelioma for the very first time in North America. It is known as pressurized intrathoracic aerosol chemotherapy (PITAC), and it delivers chemotherapy directly to the chest as a pressurized mist. One doctor knows it as “spray paint chemo.” PITAC is minimally[…]
Blood Test Did Not Reduce Late Stage Cancer Diagnoses
A major clinical trial found that a blood test designed to detect cancer early did not reduce the number of late-stage diagnoses. Grail, the manufacturer of the test, reported the findings. The results suggest multi-cancer blood tests may not be as effective as anticipated. The Galleri test looks for fragments[…]
Skip to content